Trial intelligence / Profile preview

Compound Tibetan fennel enteric soft capsule for functional dyspepsia (PDS)

CTR20211731Phase 3Terminated

Sponsor
Tianjin Institute of Pharmaceutical Research
Start
Jan 2022
Countries
1
01

Overview

A Phase 3 trial of compound Tibetan caraway enteric soft capsule in functional dyspepsia (FD), sponsored by Tianjin Institute of Pharmaceutical Research. Started Jan 2022; status: terminated.

02

Drugs

compound Tibetan caraway enteric soft capsule
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on CTR20211731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20211731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call